Symbol: PFE Sector: Healthcare Industry: Drug Manufacturers
Update: 2019-06-11 04:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2019-03-31 |
13,118,000,000 |
13,118,000,000 |
2,433,000,000 |
10,685,000,000 |
6,225,000,000 |
4,460,000,000 |
3,884,000,000 |
- |
- |
n.a. |
- |
- |
- |
- |
- |
- |
- |
1,703,000,000 |
Update: 2019-06-11 04:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2018-12-31 |
13,977,000,000 |
13,977,000,000 |
3,075,000,000 |
10,902,000,000 |
7,717,000,000 |
3,185,000,000 |
-393,000,000 |
49,926,000,000 |
159,422,000,000 |
95,664,000,000 |
63,407,000,000 |
1,225,000,000 |
8,831,000,000 |
18,833,000,000 |
41,740,000,000 |
-2,433,000,000 |
4,738,000,000 |
2,457,000,000 |
2018-09-30 |
13,298,000,000 |
13,298,000,000 |
2,694,000,000 |
10,604,000,000 |
6,755,000,000 |
3,849,000,000 |
4,114,000,000 |
41,583,000,000 |
167,838,000,000 |
96,174,000,000 |
71,319,000,000 |
3,658,000,000 |
14,770,000,000 |
17,239,000,000 |
48,422,000,000 |
948,000,000 |
5,259,000,000 |
2,008,000,000 |
2018-06-30 |
13,466,000,000 |
13,466,000,000 |
2,916,000,000 |
10,550,000,000 |
6,530,000,000 |
4,020,000,000 |
3,872,000,000 |
37,303,000,000 |
164,980,000,000 |
94,856,000,000 |
69,778,000,000 |
2,811,000,000 |
11,583,000,000 |
13,431,000,000 |
40,518,000,000 |
465,000,000 |
3,847,000,000 |
1,797,000,000 |
2018-03-31 |
12,906,000,000 |
12,906,000,000 |
2,563,000,000 |
10,343,000,000 |
6,351,000,000 |
3,992,000,000 |
3,561,000,000 |
34,835,000,000 |
164,612,000,000 |
94,071,000,000 |
70,184,000,000 |
2,416,000,000 |
9,011,000,000 |
11,421,000,000 |
40,842,000,000 |
930,000,000 |
1,983,000,000 |
1,743,000,000 |
Update: 2019-06-11 04:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2017-12-31 |
13,703,000,000 |
13,703,000,000 |
3,268,000,000 |
10,435,000,000 |
8,012,000,000 |
2,423,000,000 |
12,274,000,000 |
41,141,000,000 |
171,797,000,000 |
100,141,000,000 |
71,308,000,000 |
1,342,000,000 |
9,954,000,000 |
19,992,000,000 |
43,492,000,000 |
-1,431,000,000 |
6,757,000,000 |
2,290,000,000 |